MEI Pharma, Inc. (MEIP) financial statements (2022 and earlier)

Company profile

Business Address 11455 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments185,751153,426182,63074,489102,74353,56545,918
Cash and cash equivalents12,5518,54312,3319,59013,3098,45810,837
Short-term investments173,200144,883170,29964,89989,43445,10735,081
Contract with customer, asset10,1517,582604686
Other undisclosed current assets4,8233,80925,4107,0231,5861,758831
Total current assets:200,725164,817208,64482,198104,32955,32346,749
Noncurrent Assets
Operating lease, right-of-use asset7,3257,774 
Property, plant and equipment1,4141,5071,084204325049
Intangible assets, net (including goodwill)   261296331366
Intangible assets, net (excluding goodwill)   261296331366
Total noncurrent assets:8,7399,2811,084465328381415
TOTAL ASSETS:209,464174,098209,72882,663104,65755,70447,164
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,02114,7578,5279,3467,0973,8705,512
Accounts payable6,2566,3552,4374,7873,6435851,079
Accrued liabilities9,7658,4026,0904,5593,4543,2854,433
Deferred revenue13,51514,60914,777
Deferred revenue and credits788996 
Other undisclosed current liabilities987928 4,955   
Total current liabilities:30,52330,29423,30414,3017,8854,8665,512
Noncurrent Liabilities
Long-term debt and lease obligation6,8557,370     
Operating lease, liability6,8557,370 
Liabilities, other than long-term debt80,52772,71767,723    
Deferred revenue80,52772,71767,723
Other undisclosed noncurrent liabilities14,30922,35540,48320,43246,313  
Total noncurrent liabilities:101,691102,442108,20620,43246,313  
Total liabilities:132,214132,736131,51034,73354,1984,8665,512
Stockholders' equity
Stockholders' equity attributable to parent, including:77,25041,36278,21847,93050,45950,83841,652
Common stock, share subscribed but unissued, subscriptions receivable   (5,274)   
Additional paid in capital422,705369,171355,452279,148264,858225,169218,653
Accumulated deficit(345,455)(327,809)(277,234)(231,218)(214,399)(174,331)(177,001)
Other undisclosed stockholders' equity attributable to parent   5,274   
Total stockholders' equity:77,25041,36278,21847,93050,45950,83841,652
TOTAL LIABILITIES AND EQUITY:209,464174,098209,72882,663104,65755,70447,164

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues44,14325,53528,9134,9151,62223,249 
Revenue, net1,62223,249 
Cost of revenue
(Cost of Goods and Services Sold)
(405)(1,408)(2,671)(4,263)(3,383)(5,000) 
Gross profit:43,73824,12726,242652(1,761)18,249 
Operating expenses(104,346)(93,812)(50,782)(46,897)(26,825)(15,865)(21,004)
Operating income (loss):(60,608)(69,685)(24,540)(46,245)(28,586)2,384(21,004)
Nonoperating income819961,3951,795591287143
Investment income, nonoperating905101,3951,795591287143
Other nonoperating income (expense)(9)486     
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes18,12218,122(22,871)27,631(12,073)(1)(1)
Income (loss) from continuing operations before income taxes:(42,405)(50,567)(46,016)(16,819)(40,068)2,670(20,862)
Income tax expense (8)(1)(1)(1)(1)(1)
Other undisclosed loss from continuing operations(8)      
Income (loss) before gain (loss) on sale of properties:(42,413)(50,575)(46,017)(16,820)(40,069)2,669(20,863)
Other undisclosed net income (loss)(8,448) 111  
Net income (loss):(50,861)(50,575)(46,016)(16,819)(40,068)2,669(20,863)
Other undisclosed net income (loss) attributable to parent(3,814)    11
Net income (loss) available to common stockholders, basic:(54,675)(50,575)(46,016)(16,819)(40,068)2,670(20,862)
Other undisclosed net loss available to common stockholders, diluted(15,132)(27,394) (37,794)   
Net income (loss) available to common stockholders, diluted:(69,807)(77,969)(46,016)(54,613)(40,068)2,670(20,862)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net income (loss):(50,861)(50,575)(46,016)(16,819)(40,068)2,669(20,863)
Comprehensive income (loss), net of tax, attributable to parent:(50,861)(50,575)(46,016)(16,819)(40,068)2,669(20,863)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: